Back to company

Biomedica-Anpartsselskab: Financial statements 2021

CVR: 15234474

Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 512,204 and a net result of DKK 402,016 compared with DKK 827,644 the year before. That is a decrease of 51.9% compared with the year before. Equity amounted to DKK 1,336,566. The solvency ratio was 75.9%.

Gross Profit
512,204 kr.
Profit/Loss
402,016 kr.
Equity
1,336,566 kr.
Total Assets
1,761,822 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-512 t.402 t.1.3 mio.-
20202 mio.1.1 mio.828 t.916 t.-
20192.7 mio.1.7 mio.1.4 mio.107 t.-
2018600 t.38 t.38 t.-1.3 mio.-
20170-4 t.-4 t.-1.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Biomedica-Anpartsselskab

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Biomedica-Anpartsselskab: The 2020 annual report is outJul 1, 2021

Biomedica-Anpartsselskab has published its annual report for 2020. Revenue came to DKK 1,975,000, and the net result was DKK 827,644.

About Biomedica-Anpartsselskab

Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.